AMANDA MARSHALL: Open Payments
NPI 1154871804 · MAYSVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$999 in 54 payments from 17 companies in 2025. Trend: 2023 $621 · 2024 $867 · 2025 $999
Food & beverage: $999
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $205 |
| GlaxoSmithKline, LLC. | 8 | $137 |
| Lilly USA, LLC | 8 | $130 |
| Axsome Therapeutics, Inc. | 4 | $85 |
| Viatris Specialty LLC | 3 | $73 |
| Exact Sciences Corporation | 3 | $57 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $52 |
| Novo Nordisk Inc | 3 | $49 |
| PFIZER INC. | 3 | $43 |
| Verona Pharma, Inc. | 2 | $42 |
Products named: TRELEGY ELLIPTA, VRAYLAR, MOUNJARO, Auvelity, YUPELRI, Kerendia, Wegovy, JARDIANCE.
Industry payments across KY — which companies pay providers there.
